Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Acquiring Company
RedHill Biopharma Ltd
Acquired Company
Ferring Pharmaceuticals
Description
RedHill Biopharma announced the acquisition of exclusive global and U.S. commercialization rights to Ferring's Rebyota and Clenpiq. The deal, valued at $12 million upfront plus potential royalties, is part of RedHill's strategic repositioning in the gastrointestinal market. The drugs generated approximately $37.5 million in 2025 net sales, enhancing RedHill's commercial prospects and liquidity.
Fundz sees it the moment RedHill Biopharma Ltd makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Ferring Pharmaceuticals?
Ferring Pharmaceuticals was acquired by RedHill Biopharma Ltd, based in Raleigh. The deal was reported on September 1, 2026. RedHill Biopharma Ltd. (Nasdaq: RDHL) is a specialty biopharmaceutical company focused on developing and commercializing therapies for gastrointestinal, infectious, and oncological diseases in the U.S. RedHill Biopharma Ltd is publicly traded (RDHL) and operates in Manufacturing.
When did RedHill Biopharma Ltd acquire Ferring Pharmaceuticals?
RedHill Biopharma Ltd's acquisition of Ferring Pharmaceuticals was reported on September 1, 2026. RedHill Biopharma announced the acquisition of exclusive global and U.S. commercialization rights to Ferring's Rebyota and Clenpiq. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Ferring Pharmaceuticals do?
Ferring Pharmaceuticals is a research-driven, specialty biopharmaceutical group committed to helping people around the world build families and live better lives. It is privately held, operating in Biotechnology, and is based in Saint-Prex.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.